COO Cooper Companies, Inc. stock chart & analysis
Conviction 42HealthcareScan · Fri, Nov 6, 2026Cooper Companies, Inc. (COO) closed at $62.36 (-1.81%) on Nov 6, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 58, RS Rating 29, -30.6% from its 52-week high, -23.9% year to date. Sector: Healthcare · Ophthalmic Goods.
Financials as of Fri, Jul 31, 2026 · quarterly.
COO technical analysis
Trend
COO's moving averages are mixed — no clean uptrend or downtrend. It closed 5.3% above the 50-day ($59.20) and 8.8% below the 200-day ($68.41). ADX(14) at 25 points to a moderate trend. It meets 1 of 8 trend-template criteria.
Momentum
RSI(14) is 58, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 29 puts its weighted 12-month performance ahead of about 29% of the US market.
Volume and volatility
Volume on the latest session ran 0.6× its 20-day average. It trades about $172.7M a day on average. ATR(14) is $1.86, 3.0% of price — its typical daily range. Chaikin Money Flow (0.21) shows accumulation.
Key levels
The chart pattern's support is $53.25 and its resistance $59.89. The 52-week range is $51.01 to $89.83; price is 30.6% below the high and 22.3% above the low. The VWAP anchored at the 52-week high is $67.99, above price.
Performance
COO returned +4.7% (1 week), +14.9% (1 month), -18.3% (3 months), +4.0% (6 months), -9.4% (1 year), -23.9% (year to date).
About Cooper Companies, Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Ophthalmic Goods · Listed 1983 · 15,000 employees
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Broke outAug 141 scan
- Setting upOct 301 scan
Congress activity
Disclosed STOCK Act trades in COO · 5 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 Gilbert Cisneros house · D · CA · traded 2026-06-05 | Buy | $1K–$15K | 2026-06-05 | 2026-07-02 | |
Gilbert Cisneros house · CA · traded 2026-05-29 | Buy | $1K–$15K | 2026-05-29 | 2026-06-05 | |
Gilbert Cisneros house · CA · traded 2025-12-10 | Buy | $1K–$15K | 2025-12-10 | 2026-01-09 | |
 Rob Bresnahan house · PA · traded 2025-05-15 | Sell | $1K–$15K | 2025-05-15 | 2025-06-09 |
Insider activity
SEC Form 4 transactions in COO · open-market 5 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kurzius Lawrence Erik Director · Common Stock · 2026-09-16 | Buy | 10K | $549K | 2026-09-16 | 2026-09-17 |
Rosebrough Walter M Jr Director · Common Stock · 2026-09-14 | Buy | 3K | $163K | 2026-09-14 | 2026-09-15 |
Kurzius Lawrence Erik Director · Common Stock · 2026-09-14 | Buy | 10K | $539K | 2026-09-14 | 2026-09-15 |
Keel Paul A Director · Common Stock · 2026-09-11 | Buy | 4.7K | $250K | 2026-09-11 | 2026-09-15 |
Rosebrough Walter M Jr Director · Common Stock · 2026-09-11 | Buy | 7K | $379K | 2026-09-11 | 2026-09-15 |
Rosebrough Walter M Jr Director · Common Stock · 2026-04-01 | Exercise | 832 | $0 | 2026-04-01 | 2026-04-21 |
Rosebrough Walter M Jr Director · Restricted Stock Units · 2026-04-01 | Exercise | 832 | $0 | 2026-04-01 | 2026-04-21 |
Rosebrough Walter M Jr Director · Common Stock · 2026-01-03 | Other | — | — | 2026-01-03 | 2026-04-21 |
Rosebrough Walter M Jr Director · Restricted Stock Units · 2026-01-03 | Grant | 832 | $0 | 2026-01-03 | 2026-04-21 |
SEC filings
EDGAR filings in COO · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.